American Analyst Ratings for Wed Feb 7th

American Analyst Ratings for Wed Feb 7th

US Stock Ratings

 Analyst Ratings for Today: Insights into Market Sentiment

In today’s dynamic stock market landscape, investors are constantly seeking guidance on where to position their funds for optimal returns. Analyst ratings play a pivotal role in shaping investor sentiment, providing valuable insights into the potential performance of various stocks.

  1. Anglo American plc (AAUKF)
    • Analyst: RBC
    • Rating: Buy
    • Target Price: USD 23
    • Average Analyst Rating: Neutral

    RBC’s bullish stance on Anglo American plc reflects confidence in the company’s prospects, with a recommended target price of USD 23. Despite the neutral average analyst rating, RBC’s buy recommendation signals potential upside for investors eyeing this mining giant.

  2. Abivax SA American Depositary Shares (ABVX)
    • Analyst: Lifesci Capital
    • Rating: Buy
    • Target Price: USD 36
    • Average Analyst Rating: Bearish

    Lifesci Capital’s buy rating for Abivax SA’s American Depositary Shares contrasts with the bearish sentiment among other analysts. With a target price of USD 36, Lifesci Capital sees substantial growth potential in this biotech firm, despite the overall bearish outlook.

  3. Arcellx Inc (ACLX)
    • Analyst: Stifel Nicolaus
    • Rating: Buy
    • Target Price: USD 79
    • Average Analyst Rating: Slightly Bearish

    Stifel Nicolaus advocates for a buy position on Arcellx Inc, projecting a target price of USD 79. While the average analyst rating leans slightly bearish, Stifel Nicolaus’s confidence in ACLX’s future performance hints at significant upside for investors.

  4. Acasti Pharma Inc (ACST)
    • Analyst: Craig Hallum Capital Group
    • Rating: Buy
    • Target Price: USD 6
    • Average Analyst Rating: Slightly Bearish

    Craig Hallum Capital Group recommends a buy rating for Acasti Pharma Inc, despite the prevailing slightly bearish sentiment. With a target price of USD 6, this recommendation suggests potential growth opportunities for investors willing to take a bullish stance on ACST.

  5. Agnico Eagle Mines Limited (AEM)
    • Analyst: CIBC World Markets
    • Rating: Outperform
    • Target Price: USD 69
    • Average Analyst Rating: Bullish

    CIBC World Markets’ outperform rating for Agnico Eagle Mines highlights the company’s strong fundamentals and growth prospects. With a target price of USD 69 and a bullish average analyst rating, AEM appears poised for positive momentum in the market.

  6. Aflac Incorporated (AFL)
    • Analyst: Jefferies & Company
    • Rating: Hold
    • Target Price: USD 83
    • Average Analyst Rating: Neutral

    Jefferies & Company’s hold rating for Aflac Incorporated suggests a cautious approach to investing in this insurance giant. Despite the neutral average analyst rating, investors may find stability in AFL’s stock, with a target price of USD 83.

  7. Assurant Inc (AIZ)
    • Analyst: Bank of America Merrill Lynch
    • Rating: Buy
    • Target Price: USD 215
    • Average Analyst Rating: Neutral

    Bank of America Merrill Lynch’s buy rating for Assurant Inc underscores confidence in the company’s long-term growth prospects. With a target price of USD 215 and a neutral average analyst rating, AIZ presents an intriguing opportunity for investors seeking exposure to the insurance sector.

  8. Ametek Inc (AME)
    • Analyst: KeyBanc Capital Markets
    • Rating: Overweight
    • Target Price: USD 182
    • Average Analyst Rating: Neutral

    KeyBanc Capital Markets’ overweight rating for Ametek Inc indicates a bullish outlook on the company’s stock. Despite the neutral average analyst rating, AME’s target price of USD 182 suggests potential upside for investors positioning themselves in this industrial firm.

  9. Amgen Inc (AMGN)
    • Analyst: Bank of America Merrill Lynch
    • Rating: Hold
    • Target Price: USD 315
    • Average Analyst Rating: Slightly Bullish

    Bank of America Merrill Lynch maintains a hold rating for Amgen Inc, with a target price of USD 315. While the average analyst rating leans slightly bullish, investors may find stability in AMGN’s stock amid the pharmaceutical giant’s evolving landscape.

  10. Alpha Metallurgical Resources Inc (AMR)
    • Analyst: B. Riley Financial
    • Rating: Buy
    • Target Price: USD 40
    • Average Analyst Rating: Slightly Bullish

    B. Riley Financial’s buy rating for Alpha Metallurgical Resources suggests optimism regarding the company’s growth trajectory. With a target price of USD 40 and a slightly bullish average analyst rating, AMR presents an intriguing opportunity for investors in the mining sector.

  11. Antofagasta PLC (ANFGF)
    • Analyst: RBC
    • Rating: Buy
    • Target Price: USD 18
    • Average Analyst Rating: Slightly Bullish

    RBC’s buy rating for Antofagasta PLC reflects confidence in the company’s performance, despite the slightly bullish average analyst rating. With a target price of USD 18, ANFGF presents an attractive investment opportunity for those seeking exposure to the mining industry.

  12. Aptiv PLC (APTV)
    • Analyst: Morgan Stanley & Co.
    • Rating: Sell
    • Target Price: USD 74
    • Average Analyst Rating: Slightly Bullish

    Morgan Stanley & Co.’s sell rating for Aptiv PLC contrasts with the slightly bullish sentiment among other analysts. With a target price of USD 74, investors may consider exercising caution when evaluating APTV’s stock despite the overall positive outlook.

  13. ARB Corporation Limited (ARBFF)
    • Analyst: Ord Minnett
    • Rating: Hold
    • Target Price: USD 36
    • Average Analyst Rating: Slightly Bearish

    Ord Minnett’s hold rating for ARB Corporation Limited suggests a cautious stance on the company’s stock. Despite the slightly bearish average analyst rating, ARBFF’s target price of USD 36 indicates potential stability in the market for investors considering this automotive firm.

  14. ArcBest Corp (ARCB)
    • Analyst: Bank of America Merrill Lynch
    • Rating: Sell
    • Target Price: USD 141
    • Average Analyst Rating: Neutral

    Bank of America Merrill Lynch’s sell rating for ArcBest Corp highlights concerns regarding the company’s future performance. Despite the neutral average analyst rating, investors may exercise caution given the target price of USD 141, signaling potential downside for ARCB’s stock.

  15. Aramark Holdings (ARMK)
    • Analyst: Truist Financial
    • Rating: Buy
    • Target Price: USD 35
    • Average Analyst Rating: Slightly Bearish

    Truist Financial’s buy rating for Aramark Holdings suggests optimism regarding the company’s prospects, despite the slightly bearish sentiment among other analysts. With a target price of USD 35, investors may find potential growth opportunities in ARMK’s stock.

Full List of all Today’s Ratings

Top Trending Stocks

AVG Analyst Rating STA Analysis
StockTargetAdvisor
Buy
StockTargetAdvisor
Slightly Bullish
N/A
StockTargetAdvisor
Neutral
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Slightly Bullish
N/A
StockTargetAdvisor
Bearish
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Bullish
StockTargetAdvisor
Buy
StockTargetAdvisor
Slightly Bearish
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Slightly Bullish
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Bullish
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Neutral
StockTargetAdvisor
Buy
StockTargetAdvisor
Slightly Bullish
Ad
Ad

Leave a Reply

Your email address will not be published. Required fields are marked *